(Press-News.org) A recent study published in the Journal of Political Economy suggests that some types of intellectual property rights discourage subsequent scientific research.
"The goal of intellectual property rights – such as the patent system – is to provide incentives for the development of new technologies. However, in recent years many have expressed concerns that patents may be impeding innovation if patents on existing technologies hinder subsequent innovation," said Heidi Williams, author of the study. "We currently have very little empirical evidence on whether this is a problem in practice."
Williams investigated the sequencing of the human genome by the public Human Genome Project and the private firm Celera. Genes sequenced first by Celera were covered by a contract law-based form of intellectual property, whereas genes sequenced first by the Human Genome Project were placed in the public domain. Although Celera's intellectual property lasted a maximum of two years, it enabled Celera to sell its data for substantial fees and required firms to negotiate licensing agreements with Celera for any resulting commercial discoveries.
By linking a number of different datasets that had not previously been used by researchers, Williams was able to measure when genes were sequenced, which genes were held by Celera's intellectual property, and what subsequent investments were made in scientific research and product development on each gene. Williams' conclusion points to a persistent 20-30 percent reduction in subsequent scientific research and product development for those genes held by Celera's intellectual property.
"My take-away from this evidence is that – at least in some contexts – intellectual property can have substantial costs in terms of hindering subsequent innovation," said Williams. "The fact that these costs were – in this context – 'large enough to care about' motivates wanting to better understand whether alternative policy tools could be used to achieve a better outcome. It isn't clear that they can, although economists such as Michael Kremer have proposed some ideas on how they might. I think this is an exciting area for future work."
###
Heidi L. Williams, "Intellectual Property Rights and Innovation: Evidence from the Human Genome." Journal of Political Economy 121:1 (publishing in February 2013 issue--due to release in April).
One of the oldest and most prestigious journals in economics, the Journal of Political Economy has since 1892 presented significant research and scholarship in economic theory and practice. The journal aims to publish highly selective, widely cited articles of current relevance that will have a long-term impact on economics research.
Do intellectual property rights on existing technologies hinder subsequent innovation?
2013-03-27
ELSE PRESS RELEASES FROM THIS DATE:
Why sticking around is sometimes the better choice for males
2013-03-27
Researchers from Lund University and the University of Oxford have been able to provide one answer as to why males in many species still provide paternal care, even when their offspring may not belong to them. The study finds that, when the conditions are right, sticking around despite being 'cuckolded' actually turns out to be the most successful evolutionary strategy. The study, by Charlie Cornwallis and colleagues, is published 26 March in the open access journal PLOS Biology.
In many species, males put a lot of effort into caring for offspring that are not their ...
Researchers discover how model organism Tetrahymena plays roulette with 7 sexes
2013-03-27
It's been more than fifty years since scientists discovered that the single-celled organism Tetrahymena thermophila has seven sexes. But in all that time, they've never known how each cell's sex, or "mating type," is determined; now they do. The new findings are published 26 March in the open access journal PLOS Biology.
By identifying Tetrahymena's long-unknown mating-type genes, a team of UC Santa Barbara biologists, with research colleagues in the Institute of Hydrobiology of the Chinese Academy of Sciences, and in the J. Craig Venter Institute, also uncovered the ...
Certified stroke centers more likely to give clot-busting drugs
2013-03-27
Stroke patients are three times more likely to receive clot-busting medication if treated at a certified stroke center, according to a study in the Journal of the American Heart Association.
Intravenous tissue plasminogen activator (tPA) is the only drug approved by the Food and Drug Administration for emergency treatment for people who have ischemic (clot-caused) stroke. The durg can reduce stroke disability.
"The stroke center concept has rapidly taken off, and this data demonstrates one way that certified centers are doing better than non-certified centers," said Michael ...
Chelation therapy may result in small reduction of risk of CV events
2013-03-27
Although chelation therapy with the drug disodium EDTA has been used for many years with limited evidence of efficacy for the treatment of coronary disease, a randomized trial that included patients with a prior heart attack found that use of a chelation regimen modestly reduced the risk of a composite of adverse cardiovascular outcomes, but the findings do not support the routine use of chelation therapy for treatment of patients who have had a heart attack, according to a study in the March 27 issue of JAMA.
Chelation therapy is an intravenous administration of chelating ...
Azithromycin may provide benefit for treatment of respiratory disorder
2013-03-27
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic azithromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.
Bronchiectasis is characterized by abnormal widening of the bronchi (air tubes that branch deep into the lungs) and can cause recurrent lung infections, a disabling cough, shortness of breath, and coughing up blood. "If progressive, this process may lead to respiratory failure and the need for lung transplantation ...
Antibiotic may provide benefit for treatment of respiratory disorder
2013-03-27
Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.
David J. Serisier, M.B.B.S., D.M., F.R.A.C.P., of Mater Adult Hospital, South Brisbane, Australia, and colleagues tested the hypothesis that low-dose erythromycin would reduce pulmonary exacerbations in patients with non-CF bronchiectasis with a history of frequent exacerbations.
The study consisted of ...
Review article examines sublingual immunotherapy for treatment of allergic rhinitis and asthma
2013-03-27
In an examination of a type of treatment for allergic rhinitis and asthma that is used in Europe but not approved by the U.S. Food and Drug Administration, researchers found moderate strength in the evidence from previous studies to support the use of sublingual immunotherapy for the treatment of these conditions, according to an article in the March 27 issue of JAMA. Sublingual immunotherapy involves administration of aqueous allergens under the tongue for local absorption to desensitize the allergic individual over an extended treatment period to diminish allergic symptoms.
Allergic ...
Pining for a beetle genome
2013-03-27
The sequencing and assembly of the genome of the mountain pine beetle, Dendroctonus ponderosae, is published online this week in Genome Biology. The species is native to North America, where it is currently wreaking havoc in an area of forest ten times larger than previous outbreaks. This paper determines genes that may be involved in colonizing the trees, such as enzymes for degrading plant cell walls, and identifies potential sex chromosomes in the beetle.
D. ponderosae is a species of bark beetle, native to North America, that attacks various species of pine trees. ...
Sequencing without PCR reduces bias in measuring biodiversity
2013-03-27
DNA barcode sequencing without the amplification of DNA by PCR beats the problem of false positives which can inflate estimates of biodiversity, finds a study published in BioMed Central and BGI Shenzhen's open access journal GigaScience. This method tested on a bulk 'squashome' of mixed insect samples is also able rapidly and cost-effectively estimate biomass.
Often samples collected in the field are too small be sequenced directly. Traditionally, to get round this problem, DNA from the sample is amplified using multiple cycles of PCR. However this process is highly ...
Squished bug genomics: Insect goo aids biodiversity research
2013-03-27
March 27th, 2013, Hong Kong, China – GigaScience (a BGI and BioMed Central open access journal) announces the publication of an article that presents a new method for assessing and understanding biodiversity that uses a DNA-soup made from crushed-up insects and next generation sequencing technology. This bulk-collected insect goo has the potential to rapidly and cost-effectively reveal the diversity and make-up of both known and unknown species collected in a particular time and place. The new method devised by Xin Zhou and colleagues at BGI Shenzhen, China, is a more accurate ...